Literature DB >> 20042608

Receptor interacting protein 3 suppresses vascular smooth muscle cell growth by inhibition of the phosphoinositide 3-kinase-Akt axis.

Qian Li1, Geng Li, Xiaomei Lan, Ming Zheng, Kuang-Hueih Chen, Chun-Mei Cao, Rui-Ping Xiao.   

Abstract

Proliferation of vascular smooth muscle cells (VSMCs) is a primary mechanism underlying cardiovascular proliferative disorders. Phosphoinositide 3-kinase (PI3K)-Akt (or protein kinase B) axis has been assigned at the center of pathways that regulate cell proliferation. Here we demonstrate that enhanced PI3K-Akt signaling by mitogenic stimulation or arterial injury profoundly elevates expression of receptor interacting protein 3 (RIP3) in primary cultured rat VSMCs and in vivo and that the up-regulation of RIP3 leads to VSMC growth arrest and apoptosis via inhibiting the PI3K-Akt signaling pathway, thereby alleviating balloon injury-induced neointimal formation. Specifically, mitogenic stimulation with platelet-derived growth factor-BB or angiotensin II leads to a profound increase in RIP3 expression, which is abolished by inhibition of PI3K or Akt, and increased PI3K-Akt signaling by expression of a constitutively active PI3K mutant also elevates RIP3 expression. Importantly, adenoviral overexpression of RIP3 not only triggers apoptosis but also causes cell cycle arrest at G(1)/G(0) phases that is associated with suppressed Akt activation. In sharp contrast, RIP3 gene silencing enhances serum- and platelet-derived growth factor-induced cell proliferation and Akt activation. In vivo adenoviral gene delivery of rat RIP3 (rRIP3) increased apoptosis and reduced VSMC proliferation, thus, effectively alleviating balloon injury-induced neointimal formation. The growth-suppressive and pro-apoptotic effects are independent of rRIP3 Ser/Thr kinase activity, because overexpression of a kinase-inactive mutant of rRIP3, similar to its wild type, is sufficient to induce growth arrest and apoptosis. These findings reveal a novel growth-suppressive action of RIP3, marking RIP3 as an important factor to prevent excessive mitogenic stimulation- or injury-induced vascular smooth muscle cells hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042608      PMCID: PMC2843204          DOI: 10.1074/jbc.M109.071332

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Cellular survival: a play in three Akts.

Authors:  S R Datta; A Brunet; M E Greenberg
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

Review 2.  The phosphoinositide 3-kinase pathway.

Authors:  Lewis C Cantley
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

Review 3.  Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

Authors:  Victor J Dzau; Ruediger C Braun-Dullaeus; Daniel G Sedding
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

4.  Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3.

Authors:  Xiaoqing Sun; Jianping Yin; Melissa A Starovasnik; Wayne J Fairbrother; Vishva M Dixit
Journal:  J Biol Chem       Date:  2001-12-04       Impact factor: 5.157

5.  3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth.

Authors:  Y Hu; L Qiao; S Wang; S B Rong; E J Meuillet; M Berggren; A Gallegos; G Powis; A P Kozikowski
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

6.  Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury.

Authors:  K Shigematsu; H Koyama; N E Olson; A Cho; M A Reidy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

7.  Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model.

Authors:  Eric Durand; Ziad Mallat; Faouzi Addad; Françoise Vilde; Michel Desnos; Claude Guérot; Alain Tedgui; Antoine Lafont
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

8.  RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis.

Authors:  Duan-Wu Zhang; Jing Shao; Juan Lin; Na Zhang; Bao-Ju Lu; Sheng-Cai Lin; Meng-Qiu Dong; Jiahuai Han
Journal:  Science       Date:  2009-06-04       Impact factor: 47.728

9.  Stent implantation activates Akt in the vessel wall: role of mechanical stretch in vascular smooth muscle cells.

Authors:  Rui-Hai Zhou; Tzong-Shyuan Lee; Tsui-Chun Tsou; François Rannou; Yi-Shuan Li; Shu Chien; John Y-J Shyy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-11       Impact factor: 8.311

10.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma.

Authors:  M E Pacold; S Suire; O Perisic; S Lara-Gonzalez; C T Davis; E H Walker; P T Hawkins; L Stephens; J F Eccleston; R L Williams
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

View more
  13 in total

Review 1.  Programmed necrosis: backup to and competitor with apoptosis in the immune system.

Authors:  Jiahuai Han; Chuan-Qi Zhong; Duan-Wu Zhang
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

Review 2.  Photoreceptor cell death and rescue in retinal detachment and degenerations.

Authors:  Yusuke Murakami; Shoji Notomi; Toshio Hisatomi; Toru Nakazawa; Tatsuro Ishibashi; Joan W Miller; Demetrios G Vavvas
Journal:  Prog Retin Eye Res       Date:  2013-08-28       Impact factor: 21.198

3.  Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein.

Authors:  Guanghong Jia; Amit K Mitra; Deepak M Gangahar; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-13       Impact factor: 3.362

Review 4.  Necroptosis in cardiovascular disease - a new therapeutic target.

Authors:  Kartik Gupta; Noel Phan; Qiwei Wang; Bo Liu
Journal:  J Mol Cell Cardiol       Date:  2018-03-07       Impact factor: 5.000

5.  p55γ functional mimetic peptide N24 blocks vascular proliferative disorders.

Authors:  Jiaojiao Guo; Ning Xie; Geng Li; Yan Zhang; Fengxiang Lv; Sile Guo; Yuanqing Feng; Chun-Mei Cao; Rui-Ping Xiao
Journal:  J Mol Med (Berl)       Date:  2015-04-19       Impact factor: 4.599

6.  CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.

Authors:  Ting Zhang; Yan Zhang; Mingyao Cui; Li Jin; Yimei Wang; Fengxiang Lv; Yuli Liu; Wen Zheng; Haibao Shang; Jun Zhang; Mao Zhang; Hongkun Wu; Jiaojiao Guo; Xiuqin Zhang; Xinli Hu; Chun-Mei Cao; Rui-Ping Xiao
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

7.  Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury.

Authors:  Sanjoy Roychowdhury; Rebecca L McCullough; Carlos Sanz-Garcia; Paramananda Saikia; Naim Alkhouri; Ammar Matloob; Katherine A Pollard; Megan R McMullen; Colleen M Croniger; Laura E Nagy
Journal:  Hepatology       Date:  2016-07-17       Impact factor: 17.425

8.  RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase.

Authors:  Mitsuru Imamura; Jong-Seok Moon; Kuei-Pin Chung; Kiichi Nakahira; Thangamani Muthukumar; Roman Shingarev; Stefan W Ryter; Augustine Mk Choi; Mary E Choi
Journal:  JCI Insight       Date:  2018-02-08

9.  Mass Spectrometric Imaging Reveals Temporal and Spatial Dynamics of Bioactive Lipids in Arteries Undergoing Restenosis.

Authors:  Yatao Shi; Jillian Johnson; Bowen Wang; Bingming Chen; Gregory L Fisher; Go Urabe; Xudong Shi; K Craig Kent; Lian-Wang Guo; Lingjun Li
Journal:  J Proteome Res       Date:  2019-03-11       Impact factor: 4.466

10.  Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis.

Authors:  Jianfeng Wu; Zhe Huang; Junming Ren; Zhirong Zhang; Peng He; Yangxin Li; Jianhui Ma; Wanze Chen; Yingying Zhang; Xiaojuan Zhou; Zhentao Yang; Su-Qin Wu; Lanfen Chen; Jiahuai Han
Journal:  Cell Res       Date:  2013-07-09       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.